1
Clinical Trials associated with Dendritic Cell Vaccine(National Health Research Institutes, Taiwan)Personalized Neoantigen Derived Dendritic Cell-Based Immunotherapy as Cancer Treatment
Tumor lysate or carcinoembryonic antigen (CEA) derived DCs-based therapy is safe and can elicites remarkable T-cell responses but mostly did not really transfer into significant clinical benefit. One possible reason is the lack of effective antigen and the immunosuppressive microenvironment. Now we are exploring another new strategy, prediction of neoantigen for priming DCs as cell-based therapy with or without booster of anti-VEGF/anti-PD-1.
100 Clinical Results associated with Dendritic Cell Vaccine(National Health Research Institutes, Taiwan)
100 Translational Medicine associated with Dendritic Cell Vaccine(National Health Research Institutes, Taiwan)
100 Patents (Medical) associated with Dendritic Cell Vaccine(National Health Research Institutes, Taiwan)
100 Deals associated with Dendritic Cell Vaccine(National Health Research Institutes, Taiwan)